Relapsed/Refractory Neuroblastoma

Pediatric and Young Adult Patients with Relapsed/Refractory Neuroblastoma are asked to participate in a research study being conducted by the Cohen Children’s Medical Center of NY.

You may be eligible to participate in this study if you:

• Are at least <21 years of age • Are diagnosed with first relapse/refractory neuroblastoma You may not participate in this study if you: • Have had an allogeneic bone marrow or solid organ transplant • Have received recent (within 4 weeks prior to Cycle 1 Day 1) live vaccination • Have received systemic therapy for relapsed/refractory neuroblastoma • Have been diagnosed and/or treated with additional malignancy within 3 years • Have psychiatric illness/social situation • Have active systemic infections • Have received any prior CDK4 & 6 inhibitor • Are pregnant or breast-feeding women Contact Information Shreya Seepersaud, Study Coordinator Phone: (718) 470-7146 Email: SSEEPERSAUD2@NORTHWELL.EDU 22-10-906